Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2007 1
2008 2
2010 6
2011 2
2012 1
2013 2
2014 3
2015 8
2016 5
2017 5
2018 4
2019 6
2020 7
2021 17
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Emerging glyco-based strategies to steer immune responses.
Anderluh M, Berti F, Bzducha-Wróbel A, Chiodo F, Colombo C, Compostella F, Durlik K, Ferhati X, Holmdahl R, Jovanovic D, Kaca W, Lay L, Marinovic-Cincovic M, Marradi M, Ozil M, Polito L, Reina-Martin JJ, Reis CA, Sackstein R, Silipo A, Švajger U, Vaněk O, Yamamoto F, Richichi B, van Vliet SJ. Anderluh M, et al. FEBS J. 2021 Aug;288(16):4746-4772. doi: 10.1111/febs.15830. Epub 2021 May 15. FEBS J. 2021. PMID: 33752265 Free PMC article. Review.
CCK2R antagonists: from SAR to clinical trials.
Novak D, Anderluh M, Kolenc Peitl P. Novak D, et al. Among authors: anderluh m. Drug Discov Today. 2020 Aug;25(8):1322-1336. doi: 10.1016/j.drudis.2020.05.008. Epub 2020 May 18. Drug Discov Today. 2020. PMID: 32439608 Review.
Recent advances on smart glycoconjugate vaccines in infections and cancer.
Anderluh M, Berti F, Bzducha-Wróbel A, Chiodo F, Colombo C, Compostella F, Durlik K, Ferhati X, Holmdahl R, Jovanovic D, Kaca W, Lay L, Marinovic-Cincovic M, Marradi M, Ozil M, Polito L, Reina JJ, Reis CA, Sackstein R, Silipo A, Švajger U, Vaněk O, Yamamoto F, Richichi B, van Vliet SJ. Anderluh M, et al. FEBS J. 2021 May 2. doi: 10.1111/febs.15909. Online ahead of print. FEBS J. 2021. PMID: 33934527 Free article. Review.
New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth.
Weiss M, Loi EM, Sterle M, Balsollier C, Tomašič T, Pieters RJ, Gobec M, Anderluh M. Weiss M, et al. Among authors: anderluh m. Front Chem. 2021 Apr 14;9:666122. doi: 10.3389/fchem.2021.666122. eCollection 2021. Front Chem. 2021. PMID: 33937202 Free PMC article.
Does targeting Arg98 of FimH lead to high affinity antagonists?
Tomašič T, Rabbani S, Jakob RP, Reisner A, Jakopin Ž, Maier T, Ernst B, Anderluh M. Tomašič T, et al. Among authors: anderluh m. Eur J Med Chem. 2021 Feb 5;211:113093. doi: 10.1016/j.ejmech.2020.113093. Epub 2020 Dec 9. Eur J Med Chem. 2021. PMID: 33340913
Rutin as Deoxyribonuclease I Inhibitor.
Kolarevic A, Pavlovic A, Djordjevic A, Lazarevic J, Savic S, Kocic G, Anderluh M, Smelcerovic A. Kolarevic A, et al. Among authors: anderluh m. Chem Biodivers. 2019 May;16(5):e1900069. doi: 10.1002/cbdv.201900069. Epub 2019 Apr 10. Chem Biodivers. 2019. PMID: 30883015
Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.
Hassan M, van Klaveren S, Håkansson M, Diehl C, Kovačič R, Baussière F, Sundin AP, Dernovšek J, Walse B, Zetterberg F, Leffler H, Anderluh M, Tomašič T, Jakopin Ž, Nilsson UJ. Hassan M, et al. Among authors: anderluh m. Eur J Med Chem. 2021 Nov 5;223:113664. doi: 10.1016/j.ejmech.2021.113664. Epub 2021 Jun 25. Eur J Med Chem. 2021. PMID: 34225180 Free article.
69 results